We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Applying Deep Learning Architectures to de novo Molecular Drug Design

Video   Nov 20, 2018

 

Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.

 
More Information
 
 
Advertisement
 

Recommended Videos

SARS-CoV-2 Infected Host Cell Proteomics Reveal Potential Therapy Targets

Video

As part of the London Proteomics Discussion Group webinar series: "SARS-CoV-2: What role can proteomics play?" Dr Münch presented his work on changes in response to SARS-CoV-2 infection, highlighting potential therapies.

WATCH NOW

Testimonial: Use of Rotavapors for Drug Discovery and Formulation in Academic Research

Video

Dr. Fabiana Quaglia, Associate Professor of Pharmaceutical Technology at the Faculty of Pharmacy–University of Napoli Federico II, Italy discusses how reliability and smart features of the rotary evaporator, Rotavapor® R-300, let her easily evaporate solvents in particle production for cancer and cystic fibrosis drug development and formulation.

WATCH NOW

COVID-19 Interview: Disease Modeling Phylogenetics

Video

In this interview, Dr Emma Hodcroft, a Molecular Epidemiologist from the University of Basel, explains how disease modeling works and the impact that limitations have had on our reactions to the COVID-19 outbreak.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE